Carmignac strengthens its equity team

Carmignac has strengthened its equity investment team with the appointment of Rosie Turner as a senior healthcare analyst, reinforcing her expertise in this sector.

Rosie Turner joins Carmignac from Jefferies, where she was a senior vice president in the healthcare sell-side research department. She previously worked at Barclays Capital from 2014 to 2022 covering global healthcare companies. She started her career in 2008 at UBS Investment Bank in the global equity sales team analysing the healthcare and luxury sectors. Rosie holds a degree in Economics from Durham University.

Carmignac's investment team comprises 58 fund managers and analysts of 34 nationalities. Led by David Older, the equity investment team comprises 20 experts in European, emerging, global and thematic equities. The fund managers are supported by dedicated and experienced sector specialists, who enrich the investment process through their in-depth analysis and conviction, as well as an entrepreneurial mindset geared to today's fast-moving and constantly evolving capital markets. The team's strength lies in its ability to capitalise on global secular trends through a stock-specific bottom-up approach, backed by top-down macroeconomic analysis of the company and a strict risk management process.

Rosie is based in London and reports to David Older.